BCLI Chaim Lebovits bought BRAINSTORM CELL THERAPEUTICS INC. shares — SEC Form 4BUYBRAINSTORM CELL THERAPEUTICS INC.

Chaim Lebovits, President & CEO at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 135,000 shares at $0.38 ($51K) on 2024-05-06, disclosed to the SEC on 2024-07-31.

SEC EDGAR Filing

0001104659-24-084337

View on SEC EDGAR

Trade context

Seasonal purchase ($51k) by President & CEO — this insider has traded BCLI in May in at least three consecutive prior years. Pattern-driven, low signal.

Modest57/100

Nothing distinguishes this filing.

First-Time BuyerBuying the DipLarge Holdings IncreaseDeep Dip Buy

Trade Context

•Increased holdings by 16%
•3rd largest purchase, out of 3
•Stock up +117% in previous 6 months

Filing Info

Filed2024-07-31

Traded2024-05-06

Accession0001104659-24-084337

SourceSEC EDGAR (Historical)

Insider

NameChaim Lebovits

TitlePresident & CEO

PIT GradeInsiderUnrated

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
BCLI	BUY	2024-10-02	$11K	—	Filing →
BCLI	BUY	2024-07-31	$132K	—

Get an email when an insider at BCLI files

Free account. Follow BCLI and up to 10 more companies.

Follow BCLI for free

BCLI Chaim Lebovits bought BRAINSTORM CELL THERAPEUTICS INC. shares — SEC Form 4BUYBRAINSTORM CELL THERAPEUTICS INC.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes